Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adrenergic innervation (maintenance) refers to the ongoing role of adrenergic signaling in sustaining physiological states such as wakefulness/arousal and homeostasis within various organ systems. It involves the release of norepinephrine and epinephrine from sympathetic nerves, which act on adrenergic receptors (α₁, α₂, β₁, β₂, β₃) to regulate cardiovascular function, metabolic processes, and circadian rhythms. Disruption of adrenergic signaling can lead to various pathologies, including hypertension, cardiac arrhythmias, and sleep disorders.
Neurotransmitter release from sympathetic nerve terminals and binding to adrenergic receptors (α₁, α₂, β₁, β₂, β₃) on target tissues, leading to activation of intracellular signaling cascades.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic Innervation (Maintenance).